NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,768 Cr | ₹1,697 Cr | ₹1,212 Cr | ₹849 Cr | ₹47 Cr |
What is the latest Cash Flow from Operating Activities ratio of NATCO PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,768 Cr |
| Mar2025 | ₹1,697 Cr |
| Mar2024 | ₹1,212 Cr |
| Mar2023 | ₹849 Cr |
| Mar2022 | ₹47 Cr |
How is Cash Flow from Operating Activities of NATCO PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,768 Cr | 4.21 | |
| Mar2025 | ₹1,697 Cr | 40.05 | |
| Mar2024 | ₹1,212 Cr | 42.69 | |
| Mar2023 | ₹849 Cr | 1,726.02 | |
| Mar2022 | ₹47 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,775.5 Cr | 1.8% | 1.8% | -1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 1.8% |
1.8% |
-1% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses